日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical and genetic insights into novel TP53 mutations in De Novo AML patients

对新发急性髓系白血病患者中TP53新突变的临床和遗传学见解

Akram, Afia Muhammad; Hayat, Sikandar; Yousaf, Hassan; Sarwar, Noreen; Tahir, Asma; Ali, Sakina; Yaqoob, Fatima; Zafar, Amjad; Hassan, Hesham M; Dabiellil, Mutwakel; Khan, Malik Ihsan Ullah

Fighting malaria in Shangla District, Pakistan: insight into epidemiology, risk factors, and strategic control measures (2020-2024)

巴基斯坦尚拉地区疟疾防治:流行病学、风险因素和战略控制措施的深入分析(2020-2024 年)

Ullah, Ihsan; Baig, Ruqia Mehmood; Riaz, Aayesha; Mukhtar, Muhammad; Khan, Muhammad Ajmal; Zaib, Afia; Muhammad, Nazar; Khan, Salahuddin; Ali, Amir; Ahmad, Ajaz; Del Angel Nunez, Rosa Maria

Identification and in silico analysis of noval alteration Arg420Gly in KIT proto oncogene among acute myeloid leukemia patients

急性髓系白血病患者 KIT 原癌基因 Arg420Gly 新变异的鉴定和计算机模拟分析

Afia Muhammad Akram, Mubashir Hassan, Asma Chaudhary, Sikandar Hayat, Qurban Ali, Taha Hussain, Amjad Zafar, Muhammad Arshad Javed

Analysis of RAS gene mutations in cytogenetically normal de novo acute myeloid leukemia patients reveals some novel alterations

对细胞遗传学正常的新生急性髓系白血病患者的 RAS 基因突变进行分析,揭示了一些新的改变

Afia Muhammad Akram, Asma Chaudhary, Humera Kausar, Fayez Althobaiti, Afshan Syed Abbas, Zawar Hussain, Naz Fatima, Erum Zafar, Wajiha Asif, Umair Afzal, Zoufishan Yousaf, Amjad Zafar, Steve M Harakeh, Samina Qamer

Discovery and Protein Modeling Studies of Novel Compound Mutations Causing Resistance to Multiple Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

慢性粒细胞白血病对多种酪氨酸激酶抑制剂产生耐药性的新型化合物突变的发现和蛋白质建模研究

Zafar Iqbal, Muhammad Absar, Amer Mahmood, Aamer Aleem, Mudassar Iqbal, Abid Jameel, Tanveer Akhtar, Sajjad Karim, Mahmood Rasool, Zeenat Mirza, Muhammad Khalid, Afia Muhammad Akram, Muhammad Farooq Sabar, Ahmad M Khalid, Khalid Aljarrah, Janhangir Iqbal, Muhammad Khalid, Ijaz H Shah, Nawaf Alanazi1

Detection of Exon 12 and 14 Mutations in Janus Kinase 2 Gene Including a Novel Mutant in V617F Negative Polycythemia Vera Patients from Pakistan

在巴基斯坦真性红细胞增多症V617F阴性患者中检测到Janus激酶2基因第12和14外显子突变,包括一种新的突变体

Akram, Afia Muhammad; Kausar, Humera; Chaudhary, Asma; Khalid, Ahmad Mukhtar; Shahzad, Muhammad Mudassar; Akhtar, Muhammad Waheed; Sabar, Muhammad Farooq; Sajid, Nadia; Anazi, Nawaf Al; Aleem, Aamer; Iqbal, Zafar

Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression

在晚期慢性期和进展期伊马替尼敏感的慢性粒细胞白血病(CML)患者中发现新的复合型BCR-ABL突变,表明这些突变可能在CML进展中发挥作用。

Akram, Afia Muhammad; Iqbal, Zafar; Akhtar, Tanveer; Khalid, Ahmed Mukhtar; Sabar, Muhammad Farooq; Qazi, Mahmood Hussain; Aziz, Zeba; Sajid, Nadia; Aleem, Aamer; Rasool, Mahmood; Asif, Muhammad; Aloraibi, Saleh; Aljamaan, Khaled; Iqbal, Mudassar